Top Medical Stocks To Buy For 2018

First, a Brief Recap of Prior Predictions

Recommendation #1 Worked Well – If you have been following my work, I recommended that you sell your marijuana stocks on or about the November 8 election date, anticipating an upside over-reaction. Recommendation #2 Worked Well – I made reference in this article, where the below is a snippet:

Recommendation #3 Worked Well – I also recommended that you “buy” any marijuana stocks you liked in late December and in anticipation of late December 2016 tax loss selling followed by a January effect increase in price-per-share or recovery. That is the topic of this article. I also had a few stock picks: (1) Cannabix Technologies (OTCPK:BLOZF) is up 10%, (2) Breathtec Biomed (OTCQB:BTHCF) is up 13%, (3) Bayport International (OTCPK:BAYP) is flat, though news might result in an increase by month end – this is a risky one, and (4) Medical Marijuana (OTCPK:MJNA) is up 6%.

Top Medical Stocks To Buy For 2018: Crescent Point Energy Corp (16)

Advisors’ Opinion:

  • [By Kana Nishizawa]

    China Coal Energy Co., the countrys second-largest producer of the fuel, sank 3.1 percent after the government said it will cut coal consumption. Sun Hung Kai Properties Ltd. (16), the worlds second-biggest developer, fell 1.4 percent after trimming its sales target. Gold producers led materials companies lower as the precious metal headed for its steepest weekly loss since June amid expectations the U.S. Federal Open Market Committee will next week decide to reduce stimulus.

Top Medical Stocks To Buy For 2018: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By ]

    Next up is Fitbit (NYSE:FIT), maker of fitness tracking smartwatches. Youve probably know the company best for those little vibrating bracelets people wear to tell them how many steps theyve taken every day. But there are a bunch of different Fitbit products at various price points that can help users track their health and fitness goals.

  • [By Leo Sun]

    Under Armour (NYSE:UA) (NYSE:UAA), Fitbit (NYSE:FIT), and GoPro (NASDAQ:GPRO) were all terrible stocks to own over the past year. Under Armour and Fitbit were both cut in half, and GoPro plummeted nearly 40%.

  • [By Leo Sun]

    Many investors who watched Fitbit (NYSE:FIT) and GoPro (NASDAQ:GPRO) crash and burn may believe that demand for wearable devices — like fitness trackers and action cameras — is fading. Indeed, earlier estimates for these markets were far too bullish.

  • [By Paul Ausick]

    Fitbit Inc. (NYSE: FIT) traded down nearly 16% Tuesday and posted a new 52-week low of $4.67 after closing Monday at $5.54. The stock’s 52-week high is $7.32. Volume was more than six times the daily average of 5.4 million shares. The company reported poor results last night and offered up weak guidance as a side dish.

  • [By Bryan Murphy]

    To say Fitbit Inc (NYSE:FIT) went from being a hero to being a zero would be a considerable understatement. In 2015 shortly after its IPO, the world was certain its wearable device was going to revolutionize fitness. Less than two years later, you can barely give the things away.

    It’s enough to convince an investor to mentally write-off the idea of wearables forever. Don’t let the rise and fall (and then more fall) of FIT deter you from the industry though. Fitbit had the right idea, more or less. It just failed to adapt and improve even when it became clear its first wave of products weren’t quite what they were hoped to be for the average fitness-minded consumers (a target market that was part of the problem). There’s a young-and-hungry company called CardioComm Solutions Inc. (OTCMKTS:EKGGF, CVE:EKG) that understands exactly why Fitbit was largely sidelines, and this company has responded before committing to products that miss the mark.

    CardioComm Solutions is the name that makes wellness technology sold under the HeartCheck brand. Those devices are small, handheld ECG (electrocardiogram) readers that put the power of a doctor’s or hospital’s heart-monitoring hardware in the hands of individuals who can use them just as effectively. Its flagship products are the HeartCheck ECG Pen, for consumers – which is available without a prescription – and the HeartCheck ECG monitoring device (available only by prescription) which is a higher-functioning technology.

    More products are on the way too. The ECG ‘Card’ is a credit-card sized device that syncs up with (and is powered by) being in close proximity to a smartphone. Also on the way is the HeartCheck band, worn on the wrist. It does a lot of the same things Fitbit bands do, but with the added benefit of being able to produce clinical-grade ECG readouts viewable not just by the user, but by a doctor, clinic, or call center if that user chooses to deliver them remotely using the comp

  • [By Chris Lange]

    Fitbit Inc. (NYSE: FIT) also is set to release its most recent quarterly results on Monday. The consensus forecast calls for a net loss of $0.01 per share and $589.1 million in revenue. Shares closed on Friday at $5.28. The consensus price target is $6.64, and the 52-week range is $4.90 to $7.32.

Top Medical Stocks To Buy For 2018: Chevron Corporation(CVX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Chevron Corp. (NYSE: CVX) traded up 1.44% at $108.90. The stock’s 52-week range is $92.25 to $119.00. Volume was about 10% above the daily average of around 6.2 million shares. The integrated oil & gas company had no specific news.

  • [By Paul Ausick]

    Chevron Corp. (NYSE: CVX) traded up 0.84% at $118.70. The stock’s 52-week range is $99.61 to $119.82, and the high was posted this morning. Volume was more than 10% above the daily average of around 5 million shares. Rising crude oil prices lifted the stock Tuesday.

  • [By Elizabeth Balboa]

    It’s happened to AT&T Inc. (NYSE: T). It’s happened to Citigroup Inc (NYSE: C). It’s happened to Chevron Corporation (NYSE: CVX), General Motors Company (NYSE: GM) and Sears Holdings Corp (NASDAQ: SHLD)'s predecessor Sears, Roebuck & Co.

  • [By Paul Ausick]

    Chevron Corp. (NYSE: CVX) traded up about 0.9%, at $114.708 in a 52-week range of $102.55 to $133.88. As of last night’s close, Chevron shares are trading up about 2.5% over the past year.

Top Medical Stocks To Buy For 2018: Myers Industries, Inc.(MYE)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 0.63 percent. Meanwhile, top losers in the sector included Myers Industries, Inc. (NYSE: MYE), down 7 percent, and CF Industries Holdings, Inc. (NYSE: CF) down 6 percent.

Leave a Reply

Your email address will not be published. Required fields are marked *